baber/WOPTO huggingface dataset:
Patent CA-2435498-A1 (CA)
Title: Methods for synthesis of liquid crystals
Inventor: WELLINGHOFF STEPHEN T
IPC: C08F20/30
Filed: 2002-01-23
Abstract: Novel platform molecules and polymerizable mesogens made therefrom; novel synthetic pathways for making such platform molecules and polymerizable mesogens.
Patent CA-2435698-A1 (CA)
Title: Container, sealing cap and method for sealing a nozzle tip of a curable liquid dispensing container
Inventor: WILLIAMSON WARREN P IV
IPC: B65D53/06
Filed: 2002-01-29
Abstract: A cap (10) for curable material dispensing containers (14) prevents the material (18) from curing after opening the dispensing nozzle (12). Thus, when mounted on a partially-dispensed container (14), the nozzle cap (10) preserves flowable materials (18) such as air-cured glues, sealants, caulks, etc. In particular, a deformable sealant (44) in the cap remains pliant, conforming in and/or around the nozzle tip (32) to create a seal. A retention member (54) frictionally grips the nozzle (12) to prevent inadvertent release of the cap (10), yet accommodates nozzle tips (32) cut to varying lengths.
Patent CA-2435794-A1 (CA)
Title: Nonaqueous electrolytic solution and lithium secondary batteries
Inventor: UEKI AKIRA
IPC: H01M6/16
Filed: 2002-01-24
Abstract: The use of a nonaqueous electrolytic solution prepared by adding 0.1 to 10 w t% of a tert-alkylbenzene, preferably a combination thereof with 0.1 to 1.5 wt% of a biphenyl compound to a solution of an electrolyte in a nonaqueous solve nt is effective in producing a lithium secondary battery excellent in safety in overcharge as well as in battery characteristics such as cycle characteristics, electric capacity, and preservation characteristics.</SDOAB >
Patent CA-2435991-A1 (CA)
Title: Self cleaning shredding device having movable cleaning rings
Inventor: PARKE TERRENCE JAMES
IPC: B02C18/18
Filed: 2002-01-29
Abstract: A self clearing cutting assembly is provided, having an array of counter rotating cutters in which a plurality of cutters rotating in a first direction is mounted on a first shaft and a plurality of second cutters is mounted on a second shaft for rotating in an opposite direction. The array of cutters is provided with a plurality of clearing or cleaning rings located alternately with the cutters on each shaft. The cutting array is kept clear of debris or partially cut material by movement of the clearing or cutting rings against adjacent cutters. Movement of the clearing or cleaning rings is a combination of rotary motion and linear motion, in which the linear motion is imparted by the cutter located opposite the cleaning ring striking the cleaning rings so as to push the cleaning ring beyond the position of the widest part of the cutter to completely dislodge material from the cutter.
Patent CA-2437991-A1 (CA)
Inventor: RIVAT ALAIN
IPC: C09J175/04
Filed: 2001-02-27
Abstract: Procédé de pose d'un revêtement de sol du type constitué par un complexe souple (1), comportant une couche d'usure en matériau thermoplastique, à base de PVC plastifié notamment, les bandes élémentaires (1, 1a) constituant ledit revêtement étant collées sur le sol et soudées à froid entre elles sur le site à équiper. Il se caractérise en ce que, après mise en place et collage d'un lé (1) sur la surface à recouvrir: on applique latéralement, sur toute l'épaisseur du revêtement, un cordon (7) continu de mastic réalisé par un mélange sur le site même d'un durcisseur et d'une résine polyuréthanne en phase aqueuse; on met en place le lé (1a) consécutif sur le sol recouvert de colle et l'on fait plaquer son bord latéral contre le bord du lé précédent comportant le cordon de mastic (7), entraînant le refoulement en surface de l'excédent de matière; on élimine l'excès de mastic ainsi refoulé par simple essuyage à l'eau.
Patent CA-2438401-A1 (CA)
Title: Pharmaceutical composition
Inventor: SCHREDER SVEN
IPC: A61K47/44
Filed: 2002-01-23
Abstract: The invention relates to a pharmaceutical composition having high bioavailability for oral administration of 4-[4-(3-chloro-4-methoxybenzyl- amino)benzo[4,5]thieno[2,3-d]pyrimidin-2-yl]cyclohexanecarboxylic acid and/or 4-[4-(3-chloro-4-hydroxybenzylamino)benzo[4,5]thieno[2,3-d]-pyrimidin-2- yl]cyclohexanecarboxylic acid or pharmaceutically acceptable salts thereof, to a process for the preparation of the pharmaceutical composition, and to the use thereof.
Patent CA-2438440-A1 (CA)
Inventor: LUNDBY STEIN A
IPC: H04B7/26
Filed: 2002-01-23
Abstract: Method and apparatus for providing link quality feedback to a transmitter (32, 34). In one embodiment, a periodic link quality message is transmitted on a gated channel, while continuous differential indicators are transmitted.  Between quality messages, the differential indicators track the quality of the link. The periodic quality messages provide synchronization to the transmitter and receiver (36, 38). A coding is applied to the feedback information identifying the transmitter. In one embodiment, a remote station includes a differential analyzer (212) to determine the change in successive channel quality measurements. In an alternate embodiment, link quality feedback information is gated according to channel condition.
Patent CA-2442777-A1 (CA)
Title: Human secreted proteins
Inventor: ROSEN CRAIG A
IPC: G01N33/53
Filed: 2002-03-26
Abstract: The present invention relates to human secreted polypeptides, and isolated nucleic acid molecules encoding said polypeptides, useful for diagnosing and treating immune disorders and diseases. Antibodies that bind these polypeptides are also encompassed by the present invention. Also encompassed by the invention are vectors, host cells, and recombinant and synthetic methods for producing said polynucleotides, polypeptides, and/or antibodies. The invention further encompasses screening methods for identifying agonists and antagonists of polynucleotides and polypeptides of the invention. The present invention further encompasses methods and compositions for inhibitin g or enhancing the production and function of the polypeptides of the present invention.
Patent CA-2448534-A1 (CA)
Title: Analyse peptidique au moyen d'un support solide
Inventor: LIMINGA MARIA
IPC: G01N33/58
Filed: 2002-05-20
Abstract: La présente invention concerne une méthode d'identification d'un polypeptide. Cette méthode consiste (a) à effectuer la dérivatisation de la terminaison N du polypeptide, ou des terminaisons N d'un ou de plusieurs peptides de ce polypeptide, avec au moins un réactif acide comprenant une fraction sulfonyle couplée à une fraction acide activée en vue d'obtenir un ou plusieurs dérivés peptidiques, (b) à analyser l'un au moins de ces dérivés au moyen d'une technique spectrométrique de masse en vue de produire un modèle de fragmentation, et (c) à interpréter le modèle de fragmentation ainsi obtenu, le peptide ou le polypeptide étant immobilisé sur un support solide au moins pendant l'étape (a). Par ailleurs, la présente invention concerne une trousse destinée à identifier un polypeptide au moyen d'une technique spectrométrique de masse.
Patent CA-2449466-A1 (CA)
Title: Peripheral blood fibrocytes differentiation pathway and migration to wound sites
Inventor: DONNELLY SEAMAS
IPC: A61K35/12
Filed: 2002-06-04
Abstract: Disclosed are the identification of a differentiation pathway of cultured fibrocytes, characterization of the signals for fibrocyte migration to wound site in vivo , and the potential role of fibrocytes in wound contracture. The invention relates to a method for producing fibrocytes comprising contacting a population of human peripheral blood mononuclear cel ls (PBMC comprising predominantly CD14+ cells with autologous T cells or a form of TGF.szlig., preferably TGF.szlig.1, thereby inducing differentiation of fibrocytes from precursors in the PBMC population. These fibrocytes are usef ul for treating a wound in a mammalian subject by administering fibrocytes to t he subject, preferably in combination with TGF1. Also disclosed are methods for attracting or targeting fibrocytes to a wound by administering SLC or anothe r agonist of the CCR7 chemokine receptor, at or near the site of the wound, an d methods of decreasing undesired wound fibrosis by inhibiting fibrocyte activity.
Patent CA-2450907-A1 (CA)
Inventor: DOBETTI LUCA
IPC: B02C17/14
Filed: 2002-06-27
Abstract: L'invention concerne un procédé servant à activer des médicaments, à savoir augmenter leur solubilité et biodisponibilité. Ce procédé, mis en application dans un broyeur à vibrations, consiste à utiliser des proportions données entre le mélange physique constitué par le médicament et un véhicule pharmaceutique et le volume de vide parmi les éléments broyeurs contenus à l'intérieur du broyeur. Ce procédé permet d'obtenir des poudres à usage pharmaceutique dans lesquelles le principe médicamenteux est activé à un degré élevé et constant. On peut obtenir ce résultat indépendamment de la nature du médicament et de celle du véhicule et, également, indépendamment de leur rapport de poids.
Patent CA-2451134-A1 (CA)
Title: Appareil a jet d'air pour etirage de filaments et procede associe
Inventor: RUDISILL EDGAR N
IPC: D01D5/12
Filed: 2002-07-23
Abstract: La présente invention concerne un jet d'air destiné à l'étirage de filaments polymères thermoplastiques, comprenant une ouverture d'étirage définie par un élément d'entrée formé par un passage convergent communiquant avec un passage continu, se terminant au niveau d'une partie de sortie, un élément d'étirage comprenant une partie d'entrée dont la largeur est comprise entre 2,0 et 10 mm environ, communiquant avec ladite partie de sortie dudit élément d'entrée, et au moins une buse d'air destinée à orienter un flux d'air à grande vitesse sur lesdits filaments dans un sens aval, positionnée entre ladite partie de sortie dudit élément d'entrée et ladite partie d'entrée dudit élément d'étirage. Le rapport de l'ouverture d'étirage à la somme des ouvertures de toutes les buses est compris entre 1,0 et 10 environ.
Patent CA-2452079-A1 (CA)
Title: Procede et systeme de manipulation d'informations graphiques
Inventor: CHARPENTIER FREDERIC JEAN-LUC
IPC: G06T1/00
Filed: 2002-06-25
Abstract: Selon la présente invention, on manipule des informations graphiques selon un dispositif de calcul sur lequel des informations graphiques doivent être affichées. Les aptitudes de ce dispositif de calcul sont utilisées pour qu'un ensemble de contraintes soit formé pour les informations graphiques obtenues à partir d'un fournisseur de contenu. Ces contraintes prennent en compte des facteurs tels que les caractéristiques d'affichage du dispositif de calcul, la puissance de traitement, la mémoire disponible et les capacité de communication. Les informations graphiques sont manipulées de manières qu'elles soient en conformité avec l'ensemble de contraintes, ce qui permet d'obtenir des informations graphiques pouvant être affichées et interprétées par le dispositif de calcul.
Patent CA-2452838-A1 (CA)
Title: Apparatus, systems and methods for levitating and moving objects
Inventor: SPARKS MICHAEL T
IPC: B60L13/03
Filed: 2002-07-02
Abstract: Apparatus, systems and methods for levitating and moving objects are shown and described herein. The embodiments incorporate a track with lower rails having permanent magnets abutted against each other and aligned such that the upper surface of each of the lower rails has a uniform polarity; and the object with upper rails having permanent magnets aligned with the lower rails and oriented to oppose the polarity of the lower permanent magnets. Ferrous backing plates behind the lower rails and/or the upper rails may be incorporated. Embodiments may also incorporate a third rail of an electroconductive material, and a driving disc positioned near the third rail. Permanent magnets in the driving disc may be rotated with the driving disc in the presence of the third rail to accelerate the upper rails with respects to the lower rails.
Patent CA-2452891-A1 (CA)
Title: Sensor device for detection of dissolved hydrocarbon gases in oil filled high-voltage electrical equipment
Inventor: TILAK VINAYAK
IPC: G01N27/414
Filed: 2003-12-11
Abstract: A multi-gas sensor device (10) for the detection of dissolved hydrocarbon gases in oil-filled electrical equipment. The device (10) comprising a semiconductor substrate (14), one or more catalytic metal gate-electrodes (16) deposited on the surface of the semiconductor substrate (14) operable for sensing various gases, and an ohmic contact (22) deposited on the surface of the semiconductor substrate (14). The semiconductor substrate (14) comprises one of GaN, SiC, AlN, InN, AlGaN, InGaN and AlInGaN. A method for sensing gas in an oil-filled reservoir of electrical equipment, comprising providing a sensor device (10), immersing the sensor device (10) in the oil-filled reservoir, allowing the gases emitted from the oil to interact with the one or more catalytic metal gate-electrodes (16), altering the gas as it contacts the catalytic metal gate-electrodes (16) and altering the sensitivity of the sensor.
Patent CA-2454347-A1 (CA)
Title: Eosinophil prostaglandin d2 receptor assays
Inventor: NANTEL FRANCOIS
IPC: G01N33/88
Filed: 2002-07-17
Abstract: The present invention identifies different activities mediated by eosinophil PGD2 receptors and features methods measuring the ability of a compound to modulate such activities. Activities mediated by eosinophil PGD2 receptors include those associated with CRHT2 and those associated with the DP recepto r. Activities identified herein as associated with eosinophil CRHT2 include a change in cell morphology, degranulation, and a specific chemokinetic effect . Activities identified herein as associated with the eosinophil DP receptor include resistance to apoptosis.
Patent CA-2455252-A1 (CA)
Title: Surgical navigation instrument useful in marking anatomical structures
Inventor: GRIMM JAMES E
IPC: A61B19/00
Filed: 2004-01-16
Abstract: A surgical instrument having a grip, a reference structure and an alignment head and method of using. The reference structure has at least one reference element that is registrable in a computer assisted navigation system. The reference element may be a reflective structure for use in an optical tracking system, wire loop for sensing a magnetic field, or other suitable device. The alignment head has a substantially planar alignment surface and may also have a plurality of outwardly extending projections or an electrocautery electrode disposed along an edge of the alignment surface and extending parallel to the alignment surface. The projections may be engaged with an anatomical structure to hold the alignment head in a desired position as the alignment surface is used as a guide to mark the anatomical structure. The disclosed instrument may be used when resecting a femur to prepare the femur to receive the femoral component of a prosthetic hip joint.
Patent CA-2456318-A1 (CA)
Inventor: GAUL MICHAEL A
IPC: H04N7/173
Filed: 2002-08-06
Abstract: One embodiment of the present invention provides a system and method for configuring an interactive program guide (IPG). In one embodiment, a method for configuring an IPG (100) includes receiving user input requesting a change in configuration of an IPG (105) and providing the user with an IPG that is configured in accordance with user input.
Patent CA-2458085-A1 (CA)
Inventor: WEYER KARL
IPC: C12Q1/68
Filed: 2004-03-16
Abstract: The present invention provides a novel method for determining the biological activity of a compound comprising the steps of a) contacting a host pith a compound; b) determining the general transcriptional gene response of the host; and c) quantitating the general transcriptional gene response induced by said compound.
Patent CA-2460180-A1 (CA)
Title: Microbiocidal n-phenyl-n-[4-(4-pyridyl)-2-pyrimidin-2-yl]-amine derivatives
Inventor: CEDERBAUM FREDRIK EMIL MALCOLM
IPC: C07D401/04
Filed: 2002-12-05
Abstract: Fungicidal compounds of Formula (I) wherein m is 0, 1, 2 or 3 ; n and p are independently of each other 0 or 1; R1 is halogen, optionally substituted alkyl, optionally substituted alkoxy, optionally substituted alkenyloxy, optionally substituted alkynyloxy, optionally substituted thioalkyl optional ly substituted aryl, COOR11, CONR12R13, S(O)qR14, SO2NR15R16 or NR15aR16a; q is 1 or 2; and R2, R2a, R3, R4, R5, R6, R7, R8, R9, R10, R11, R12, R13, R14, R15, R16, R15a, R16a, are specified organic groups or a salt thereof; their preparation and compositions containing them.
Patent CA-2460485-A1 (CA)
Inventor: DUNN WILLIAM
IPC: G01M99/00
Filed: 2002-09-16
Abstract: L'invention concerne un procédé et un système destinés à tester de façon automatique des écrans de visualisation et à optimiser de façon automatique les réglages de tension pour chaque écran de visualisation étant testé par harmonisation et individualisation des réglages de tension appliqué à l'écran et à régler de façon automatique dans la mémoire les coefficients permettant d'atteindre les niveaux de tension optimisé pour chaque écran de visualisation.
Patent CA-2463114-A1 (CA)
Title: Procede et dispositif de comparaison de phase et de frequence
Inventor: PICHARD FABRICE
IPC: H03L7/093
Filed: 2002-11-07
Abstract: Le comparateur de phase et de fréquence pour asservir la fréquence et la phase (F¿vco?) du signal de sortie d'un oscillateur commandé en fréquence, en fonction de la fréquence (F¿ref?) et de la phase d'un signal de référence (S¿ref?), comprend des moyens (11, 12, 21, 22) pour détecter dans chacun des signaux de référence (S¿ref?) et provenant de l'oscillateur des événements représentatifs de la fréquence et de la phase du signal, des moyens (S1?+¿, SI?-¿, 16, 17) pour générer un premier ou second signal, lors de la détection d'un événement, des moyens (S2?+¿, S2?-¿, 24 à 27) pour générer un troisième ou quatrième signal, lors de la détection d'un événement, si respectivement le premier ou second signal est généré, des moyens pour appliquer tous les signaux générés (I¿o? ; V¿o?) à l'oscillateur, des moyens (13, 23) pour arrêter la génération des premier et second signaux ou de tous les signaux lorsque respectivement les premier et second signaux ou les troisième et quatrième signaux sont générés simultanément.
Patent CA-2467940-A1 (CA)
Title: Improved radiopacity intraluminal medical device
Inventor: PELTON ALAN
IPC: A61L31/18
Filed: 2004-05-20
Abstract: A stent or other intraluminal medical device having markers formed from housings integral with the stent and marker inserts having a higher radiopacity than the stent provides for more precise placement and post-procedural visualization in a vessel, by increasing the radiopacity of the stent under-X-ray fluoroscopy. The housings are formed integral to the stent and the marker inserts are made from a material close in the galvanic series to the stent material and sized to substantially minimize the effect of galvanic corrosion. The housings are also shaped to minimize their impact on the overall profile of the stent. The stent or other intraluminal medical device may also be fabricated from an alloy having a higher radiopacity without sacrificing any properties of the base alloy forming the stent or other intraluminal medical device.
Patent CA-2468696-A1 (CA)
Inventor: BRANDENBURG CHARLES J
IPC: C08F271/00
Filed: 2002-11-27
Abstract: L'invention concerne des polymères greffés acryliques élastiques comprenant des monomères d'.alpha.-méthylène-lact(one)(ame) tels que de l'.alpha.-méthylène-.gamma.-butyrolactone, et des mélanges de tels polymères avec des résines de matrices thermoplastiques. Cette invention concerne également des polymères greffés acryliques non élastiques et durs comprenant des monomères d'.alpha.-méthylène-lact(one)(ame) tels que de l'.alpha.-méthylène-.gamma.-butyrolactone, et des mélanges de tels polymères avec des résines de matrices thermoplastiques. L'invention se rapporte en outre à un procédé général de polymérisation en émulsion de monomères d'.alpha.-méthylène-lact(one)(ame) tels que l'.alpha.-méthylène-.gamma.-butyrolactone et ses copolymères.
Patent CA-2469315-A1 (CA)
Title: Pharmaceutical nanoparticulate composition of a tachykinin receptor antagonist
Inventor: THOMPSON KAREN C
IPC: A61K31/5377
Filed: 2002-12-09
Abstract: The present invention is directed to novel pharmaceutical compositions of the compound 2-(R)-(1-(R)-(3,5-bis(trifluoromethyl)phenyl)ethoxy)-3-(S)-(4-fluoro)phenyl-4-(3-(5-oxo-1H,4H-1,2,4-triazolo)methylmorpholine. The pharmaceutical compositions of this invention useful in the treatment or prevention of disorders such as psychiatric disorders including depression and anxiety, inflammatory diseases and emesis.
Patent CA-2471443-A1 (CA)
Title: Process for making stable protein based acid beverage
Inventor: SHEN CHENG
IPC: A23L2/66
Filed: 2004-06-17
Abstract: This invention is directed to a process for preparing a stable suspension of a protein material in an acidic beverage, comprising; blending (A) a hydrated and homogenized protein material slurry with (B) a hydrated protein stabilizing agent-acid dispersion, and pasteurizing and homogenizing the blend.        In an alternative embodiment, the invention is directed to a process for preparing a stable suspension of a protein material in an acidic beverage, comprising; blending (A') a hydrated and homogenized protein material-protein stabilizing agent slurry with (B) a hydrated protein stabilizing agent-acid dispersion, and pasteurizing and homogenizing the blend.
Patent CA-2471457-A1 (CA)
Inventor: JONES ROBERT L
IPC: H04N1/32
Filed: 2002-12-24
Abstract: La présente invention concerne un procédé de production d'un document d'identification (100). Ce procédé consiste à fournir un substrat configuré et conçu pour être imprimé, et à imprimer une première indication variable sur ce substrat. Cette première indication variable (16) n'est pas visible à l'oeil humain en lumière ambiante, mais elle est visible à l'oeil humain lorsqu'elle est visualisée au moyen d'un premier type de lumière.
Patent CA-2473326-A1 (CA)
Title: Method to block unauthorized access to tftp server configuration files
Inventor: GOULD KENNETH
IPC: H04L9/32
Filed: 2004-07-08
Abstract: The present invention teaches methods and systems for blocking unauthorized access to cable modem configuration files stored on trivial file transfer protocol (TFTP) servers. Filenames are modified by the DHCP to incorporate an authentication key (and optional cloaking) prior to transmission to the cable modem. When the TFTP server receives a modified filename, it also generates an authentication key. The authentication keys must match in order for the cable modem to receive the configuration file requested. At a minimum, authentication keys depend upon the un-modified filename, the cable modem IP address and a "coordination pass phrase" known to the TFTP server and DHCP server, but not known to the cable modem. Variations include optional cloaking, various actions performed for non-matching authentication keys, selection of authentication key generating algorithm and inclusion of cable modem MAC address in the authentication key for all cable modems or for premium service customer cable modems.
Patent CA-2473394-A1 (CA)
Inventor: MEINERT HASSO
IPC: C10M105/52
Filed: 1996-08-09
Abstract: Fluorinated alkanes (I) of formula F(CF2)n(CH2)mH (Ia) and F(CF2)n(CH2)m(CF2)nF (Ib) are new. n = 1-20; m = 3-20. Also claimed is a fluorinated n-alkane with density 1.1-1.3 g/cm<3>.
Patent CA-2474497-A1 (CA)
Inventor: GAGLIA JASON L
IPC: A61P35/00
Filed: 2003-01-30
Abstract: Cette invention concerne des compositions et des méthodes permettant de promouvoir ou de réduire la circulation de lymphocytes T vers un tissu cible. Cette invention concerne également des compositions et des méthodes permettant de promouvoir ou d'inhiber l'activation de cellules de présentation de l'antigène (APC). Cette invention porte sur la découverte de caractéristiques fonctionnelles de TIM-3 qui est une molécule de préférence exprimée sur la surface de cellules Th1. Ces méthodes servent à traiter des troubles tels que le cancer, les maladies infectieuses, les allergies, l'asthme et les maladies auto-immunes.